Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral mimicry evasion: a new role for oncogenic KRAS mutations.

Molecular oncology - 1 Feb 2025

Chen Raymond, He Aobo, De Carvalho Daniel D

Abstract excerpt

"Viral mimicry" refers to the induction of an innate immune response and interferon signaling by endogenous stimuli such as double-stranded RNA (dsRNA). This response has been shown to have strong cancer therapeutic potential, including by enhancing the effectiveness of immune checkpoint inhibition (ICI) therapies, and may represent a tumor suppression mechanism that needs to be overcome for malignant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to KRAS gene
Share to STAT3 gene
Share to Molecular Mimicry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Share to RNA, Double-Stranded

Source

Open in PubMed Open full text

Identifiers

PMID: 39592415
DOI: 10.1002/1878-0261.13771
PMCID: PMC11792985

Genes

DDX60
KRAS
STAT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral mimicry evasion: a new role for oncogenic KRAS mutations.PMID 39592415Read ↗

Unveiling the role of KRAS in tumor immune microenvironment.Semantic proximity Read ↗

KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of ImmunotherapySemantic proximity Read ↗

Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systemsSemantic proximity Read ↗

Immune modulatory effects of oncogenic KRAS in cancerSemantic proximity Read ↗

Targeting Mutant KRAS for Immunogenic Cell Death Induction.Semantic proximity Read ↗

Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T‐Cells to Activation‐Induced Cell Death in Colorectal CancerSemantic proximity Read ↗

KRAS G12C inhibition and innate immune targeting.Semantic proximity Read ↗

GI-4000 in KRAS mutant cancers.Semantic proximity Read ↗

KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.Semantic proximity Read ↗

Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.Semantic proximity Read ↗

The AUTACE That Degrades KRAS and Engages CD8+ T Cells for the Treatment of KRAS/TP53 Co-Mutant Tumors.Semantic proximity Read ↗

KRAS drives immune evasion in a genetic model of pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.